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Abstract
W e have studied the expression and distribution patterns of the interm ediate filam ent proteins desm in and vimentin, the  
sarcomere com ponents titin, nebulin and myosin, the basem ent membrane constituents collagen type IV  and laminin, and the  
reticular layer com ponent collagen type VI in skeletal m uscle of patients w ith  “classic” congenita l m yopathies (CM), using  
indirect im m unofluorescence assays. In all biopsy specimens obtained from patients with central core disease (C C D ), nem aline  
myopathy (N M ), X -linked myotubular myopathy (XLM TM ) and centronuclear m yopathy (C N M ), d isease-specific  desm in  
disturbances w ere observed. Vim entin was present in immature fibres in severe neonatal N M , and as sarcoplasm ic aggregates in 
one case of CNM , w hile the amounts of vimentin and embryonic myosin, observed in X L M T M , decreased w ith  age o f  the  
patients. Abnorm al expression of myosin isoforms was found in several CM biopsies, although the  organization o f  myosin and  
other sarcomere com ponents was rarely disturbed. Basem ent membrane and reticular layer proteins were o ften  prominently  
increased in severe cases o f  CM. W e conclude that (i) desmin is a marker for individual types o f  CM  and m ight be used for 
diagnostic purposes; (ii) the expression patterns of the differentiation markers desm in, v im entin  and embryonic myosin in 
XLM TM , point either to a postnatal muscle fibre maturation or to a variable tim e-point o f  m aturational arrest in individual 
patients; (iii) the correlation between the distribution patterns of extracellular matrix proteins and clinical presentation points to 
a role of these proteins in pathophysiology of CM.
Keywords: Congenital myopathies; Central core disease; N em aline (rod) myopathy; C en tron u clear /m yotu b u lar  myopathy; 
M uscle fibre maturation; Immunocytochemistry
1. Introduction
Defined as inherited non-progressive childhood 
neuromuscular diseases, characterized by specific clini­
cal features and structural abnormalities within the 
skeletal muscle, the group of congenital myopathies 
(CM) now includes some forty distinct disorders. These 
rare diseases can be divided into three categories as
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recently reviewed by Goebel (1991): (i) “classic” CM, 
such as central core disease (CCD), nemaline myopa­
thy (NM), centronuclear myopathy (CNM), X-linked 
myotubular myopathy (XLMTM) and congenital fibre 
type disproportion (CFTD); (ii) “accepted” CM, often 
named after the morphology of structural changes ob­
served in the muscles (e.g. fingerprint body myopathy 
and zebra body myopathy); and (iii) “questionable55 
CM, a large group of less well defined muscular dis­
eases.
CCD is the first CM reported in the literature. Shy 
and Magee (1956) described a family suffering from
200 P.F.M. van der Ven et aL /Journal o f  the Neurological Sciences 129 (1995) 199—213
non-progressive, mild muscle weakness, which after 
histologic examination revealed muscle fibres with ab­
normal central areas, that were later shown to be 
devoid of mitochondria and sarcoplasmic reticulum 
and deficient in oxidative enzymes and phosphorylase 
activity (Bodensteiner, 1994). The myofibrils in those 
areas or cores are either disrupted (unstructured cores) 
or show a normal cross-striation (structured cores). In 
the latter case myofibrils are often contracted or other­
wise out of register with the fibrils outside the core 
(Bodensteiner, 1994).
NM was described for the first time by Shy et al. 
(1963) and Conen et al. (1963) as a mild, non-progres­
sive muscle weakness characterized by rod-like struc­
tures within the myofibres, which was confirmed by 
Engel et al. (1964) and Kuitunen et al. (1972), Subse­
quent reports described patients with myofibrillar as 
well as nuclear rods (Paulus et al., 1988; Rifai et al., 
1993). Apart from relatively benign cases, severely af­
fected and progressive cases have also been described 
(Nonaka et al., 1989,1990; Shimomura and Nonaka, 
1989; Wallgren-Pettersson, 1989). Bodensteiner (1988) 
suggested to classify the neonatal and congenital forms 
of NM and the adult onset form as separate disease 
entities. Evidence was presented that NM is inherited 
as an autosomal dominant trait (Arts et al., 1978; 
Kondo and Yuasa, 1980), although in some families 
autosomal recessive inheritance was suggested (Arts et
al., 1978; Cartwright et al., 1990).
A myopathy characterized by the presence of cen­
tral nuclei in the muscle fibres was described for the 
first time by Spiro et al. (1966). This author introduced 
the term “myotubular myopathy55. Together with 
“centronuclear myopathy” (Sher et a l, 1967) this term 
has since then often been used for myopathies distin­
guished by non-peripherally located nuclei in muscle 
fibres. Nowadays most authors discern two or three 
different types of myopathies with centrally located 
nuclei (Dubowitz, 1985; Swash and Schwartz, 1988; 
Bodensteiner, 1994). A  convenient classification pro­
posed by Figarella-Branger et al. (1992), categorizes all 
non-X-linked types in one group, and the X-linked 
form in a second group. In this paper we will refer to 
the non-X-linked cases as centronuclear myopathies 
(CNM) and to the X-linked cases as X-linked myotubu­
lar myopathy (XLMTM). XLMTM, first described by 
Van Wijngaarden et al. (1969) and Barth et al. (1975), 
is undoubtedly the most severe CM. Symptoms are 
always present at birth and patients usually die within 
a few months. Muscle biopsies are characterized by 
small fibres with large central nuclei that show features 
of immaturity or a delayed development (Sarnat, 1990). 
The affected gene in XLMTM has been assigned to 
Xq28 (Darnfors et al., 1990; Lehesjoki et al., 1990; 
Starr et al., 1990; Thomas et al., 1990).
CNM has its onset in childhood or in adult life
(Goebel et al., 1984; Lovaste et al., 1987; Van der Ven 
et al., 1991) and usually results in somewhat milder 
symptoms. An autosomal recessive (Sher et al., 1967; 
Heckmatt et al, 1985) as well as an autosomal domi­
nant (McLeod et al., 1972; Torres et al., 1985) inheri­
tance has been suggested. Mostly, the often sporadic 
childhood or adult life onset cases are even more 
benign, although progressive cases have also been de­
scribed (Baradello et al., 1989).
The molecular organization and distribution of 
structural muscle fibre components in CM have only 
scarcely been studied. Abnormal desmin distribution 
has been described in CCD (Thornell et al,, 1983; 
Gallanti et al., 1992), NM (Jockusch et al., 1980; Thor­
nell et al., 1980; Sarnat, 1992), XLMTM (Sarnat,
1990.1992) and CNM (Van der Ven et al., 1991; Misra 
et al., 1992; Figarella-Branger et al., 1992), while aber­
rant expression of vimentin, other than in regenerating 
fibres, has been reported in XLMTM (Sarnat,
1990.1992) and CNM (Van der Ven et al., 1991; Misra 
et al., 1992).
The sarcoplasmic rods characteristic for NM were 
shown to contain the Z-band protein a-actinin 
(Jockusch et al., 1980; Jennekens et al., 1983; Paulus et 
al., 1988) and actin (Yamaguchi et al., 1982; Rifai et 
al., 1993). Whether desmin is a component of rods 
(Paulus et al., 1988; Rifai et al., 1993) or just associated 
with them (Jockusch et al., 1980) is still not clear. The 
presence of vimentin in rods has to date been de­
scribed in a single report (Paulus et al., 1988). Intra­
nuclear rods differ in composition from their sarco­
plasmic counterparts in that only the presence of a- 
actinin could be demonstrated (Paulus et al., 1988; 
Rifai et a l, 1993).
Embryonic myosin was found to be expressed in 
XLMTM (Sawchak et aL, 1991) and an overrepresenta­
tion of either fast or slow twitch fibres was demon­
strated in cases of CCD (Dubowitz, 1985; Swash and 
Schwartz, 1988) and NM (Biral et al., 1985; Shimomura 
et al., 1989). Antibodies specific for basement mem­
brane and reticular layer proteins have been used in 
very few studies concerning CM (Dunn et al., 1984; 
Hantai et al., 1985). In some cases of CNM only a 
thickening of the basement membrane of a few atro­
phic fibres was observed (Bertolotto et al., 1983), while 
in one case of CNM the increased expression of laminin 
and collagen type IV surrounding all muscle fibres and 
blood vessels was ultrastructurally shown to be the 
result of a reduplication of the basement membrane 
(Van der Ven et al., 1991).
We previously described abnormalities in the distri­
bution of intermediate filament proteins and compo­
nents of the basement membrane and the reticular 
layer in skeletal muscle of a case of CNM (Van der 
Ven et al., 1991). This report describes a systematic 
and extensive study in a large group of CM patients
Table 1
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CCD1 F By mild delay in milestones
CCD2 F lOy generalized moderate muscle weakness
CCD3 M lOy normal developmental milestones
CCD4 F 13y progressive muscle weakness; daughter of CCD5
CCD5 M 34y mild symptoms; father of CCD4
NM1 M 9m severe neonatal form
NM2 F 14m moderate, congenital form; marked delay in milestones
NM3 F 19m severe neonatal form
NM4 M 23y adult onset form; mild generalized muscle weakness
NM5 F 34y adult onset form; progressive; severely affected; autosomal dominant trait
XLMTM 1 M ld severe neonatal form
XLMTM2 M 1 m severe neonatal form
XLMTM3 M 2m severe neonatal form
XLMTM4 M 4m severe neonatal form
CNM1 F 8y mild congenital form
CNM2 M lOy childhood onset; progressive, generalized muscle weakness
CM: congenital myopathy; PNo: patient number; CCD: central core disease: NM nemaline (rod) myopathy; XLMTM: X-linked myotubular 
myopathy; CNM: centronnclear myopathy; Age: age at time of biopsy.
with several antibodies specific for cytoskeletal, sar- 
comeric, basement membrane and reticular layer pro­
teins. Serial sections were studied and double labelling 
experiments were performed to allow the comparison 
of different components within the same muscle fibre.
2. Materials and methods
Muscle biopsies
Skeletal muscle biopsies from 16 patients suffering 
from a congenital myopathy were examined in this 
study (Table 1). In all cases the diagnosis was made
after clinical investigation and a standard series of 
histochemical investigations (Dubowitz, 1985). Electron 
microscopy was applied in a number of cases in order 
to confirm the diagnosis.
JmmunohistochemisUy
Immunohistochemical studies, using the indirect im­
munofluorescence technique, were performed as de­
scribed before (Van der Ven et al., 1991), except that 
in most experiments non-fixed cryosections or sections 
treated for 5 min with 0.5% Triton X-100 in phosphate 
buffered saline were used. The characteristics of the
Table 2
Antibodies and antisera used in this study
Antigen Designation M /R Source Reference
Desmin RD301 M ED Ramaekers et al. 1987
D3 M F Danto and Fischman 1984
pDes R ED Ramaekers et al. 1985
Vimentin RV202 M ED Ramaekers et al. 1985
pVim R ED Ramaekers et al. 1983
Myosin, sarcomeric (MHC) MF20 M F Bader et al. 1982
Myosin, fast (MLC) MF5 M DSHB Shimizu et al. 1985
Myosin, slow (MHC) 219-1D1 M W
Myosin, embryonic (MHC) 330-R5B4 M W Wessels et al. 1990
330-R5D4 M w Wessels et al. 1990
Nebulin NB2 M s Fürst et ah 1988
Titin 9D10 M DSHB Wang and Greaser 1985
Laminin 2E8 M DSHB Engvall et al. 1986
Collagen type IV M3F7 M DSHB Foellmer et al. 1983
Collagen type VI 5C6 M DSHB Hessle and Engvall 1984
M: mouse monoclonal antibody; R: rabbit antiserum; ED: available from EuroDiagnostica BV, Apeldoorn, The Netherlands; F: kind gifts of Dr 
D. Fischman, New York, NY, USA; DSHB: obtained from the Developmental Studies Hybridoma Bank, maintained by the Department of 
Pharmacology and Molecular Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, USA and the Department of Biology, 
University of Iowa, Iowa City, IA, USA, under contract N01-HD-6-2915 from the NTCHD; W: kind gifts of Dr A. Wessels, Amsterdam, The 
Netherlands; S: purchased from Sigma Chemical Company, St. Louis, MO, USA; MHC: myosin heavy chain; MLC: myosin light chain
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antibodies used in this study are summarized in Table
2. None of the reactivity patterns was observed after 
omission of the primary antibodies. In double-labelling 
experiments, the observed reactivity patterns did not 
differ from those of the individual antibodies in paral­
lel experiments.
3. Results
The results of the immunohistochemical studies on 
skeletal muscle sections of patients suffering from CCD, 
NM, XLMTM and CNM are summarized in Tables 3 
and 4 and illustrated in Figs. 1-6.
Table 3




















strong staining of aggregates in 
cores
most cores negative with a flu­
orescent demarcation
cores negative to strongly 
stained; often staining of ag­
gregates
cores negative or with aggre­
gates; fluorescent demarcation 
of cores
in most cores staining of aggre­
gates; fluorescent demarcation 
of cores
patchy to diffuse overall stain­
ing of most fibres
disturbed in some small fibres
increased staining of most fi­
bres
organization exclusively dis­
turbed in small fibres
organization disturbed in most 
fibres; presence of core-like 
structures
strong central staining in
> 90% of the fibres; cross stri­
ations
strong central staining in
> 90% of the fibres; cross stri­
ations
strong central staining in most 
small and some large fibres
strong central staining in 
> 90% of the fibres; cross-stri- 
ations
organization disturbed in most 
small fibres
organization disturbed in nu­
merous fibres
Vimentin Slow/fast myosin Embryonic myosin
no staining of muscle 
fibres




no staining of muscle 
fibres
almost exclusively ( > 99%) 
slow-twitch fibres 
all fibres slow-twitch
only 1 positive fibre
only few ( < 1 %) posi 
tive fibres
all fibres slow-twitch no positive fibres
no staining of muscle predominance ( >  99%) of no positive fibres 
fibres slow-twitch fibres
no staining of muscle 
fibres
diffuse staining of espe­
cially small fibres
no staining of muscle 
fibres
no staining of muscle 
fibres
no staining of muscle 
fibres
no staining of muscle 
fibres
strong central staining 
in most small fibres; 
cross striations 
strong central staining 
in small fibres
predominance (80%) of slow- 
twitch fibres, cores exclusively 
in slow-twitch fibres 
small fibres predominantly 
fast-twitch, large fibres pre­
dominantly slow-twitch some­
times stained
small fibres predominantly 
slow-twitch, large fibres pre­
dominantly fast-twitch 
predominance of slow-twitch 
fibres ( >  95%), few small 
fast-twitch fibres 
large fibres exclusively fast- 
twitch, small fibres exclusively 
slow-twitch
ATPase: predominance 
(>  99%) of slow-twitch fibres
normal differentiation in fast- 
twitch and slow-twitch fibres
central staining in 
< 10% of the fibres
normal differentiation in fast- 
twitch and slow-twitch fibres; 
fast-twitch fibres smaller 
normal differentiation in fast- 
twitch and slow-twitch fibres
central staining in very normal differentiation in fast- 
few small fibres twitch and slow-twitch fibres
no staining of muscle 
fibres
punctate staining in sev­
eral fibres
small fibres > 90% slow- 
twitch; predominance of slow- 
twitch fibres
normal differentiation in fast- 
twitch and slow-twitch fibres
no positive fibres
small fibres often, large 
fibres
no positive fibres
very few positive fibres
no positive fibres
nd
negative to strongly pos­
itive fibres throughout 
biopsy
negative to strongly pos­
itive fibres throughout 
biopsy
negative to strongly pos­
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Central core disease (CCD; Fig. 1)
In all five CCD patients studied, desmin staining 
was normal apart from the central cores, which were 
often negative, and separated from the rest of the fibre 
by a fluorescent demarcation (Fig. 1A). A  strong fluo­
rescence of the cores (Fig. 1A) or a staining of desmin 
aggregates within the cores (Fig. IB) was also observed. 
These different desmin patterns occurred next to each
other within biopsies of individual patients. Vimentin 
reactivity was never found in CCD muscle fibres. In 
one patient (CCD2) the increased connective tissue 
compartment was strongly stained by anti-vimentin (Fig. 
1C). Ail biopsies showed a conspicuous predominance 
of slow fibres. Embryonic myosin was never detected in 
more than a few small, regenerating fibres. Basement 
membrane protein expression was slightly or strongly
Fig. 1. Central core disease. Immunofluorescence micrographs of muscle tissue of patients CCD1 (DjK), CCD2 (A,C,E,G,H), CCD3 (B,F,I) and 
CCD4 (K) incubated with polyclonal anti-desmin (A,B), polyclonal anti-vimentin (C), anti-sarcomeric myosin heavy chain (D), anti-laminin (E,F), 
anti-collagen type IV (G), anti-collagen type VI (H,I), or anti-titin (J,K). Note the presence of desmin negative cores (arrow in A) and strongly 
stained cores (arrowhead in A) in one and the same tissue section (A). J and K depict the absence of titin in some cores (K, arrow) while other 
cores show a disturbance of the cross-striated pattern (arrow in J). Bar =  50 /xm (A,B>D,J,K) or 100 /¿m (C,E-I).
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Fig. 2. Nemaline myopathy. Gomori trichrome (A,B) or immunofluorescent (C-L) staining of muscle tissue of patients NM1 (F-J), NM2 (B,K), 
NM3 (A,L), NM4 (E) or NM5 (C,D). Sections are incubated with monoclonal anti-desmin RD301 (C,D), polyclonal anti-desmin (E,F), polyclonal 
anti-vimentin (G), anti-embryonic myosin (330-R5B4, H), anti-collagen type IV (I), anti-collagen type VI (J,K) and anti-titin (L). Some Gomori 
trichrome stained areas in A,B are indicated by arrows. Bar = 50 ¡xm (A,B,D-L) or 100 fim  (C),
increased in CCD4 and CCD2 (Fig. IE) respectively, 
while normal' reactivity was seen in the other cases 
(Fig. IF). In one patient expression of the basement 
membrane protein collagen type IV was observed in 
the perimysial tissue (Fig. 1G). Endomysial and/or  
perimysial staining of collagen type VI was increased in 
four patients (Fig. 1H) and normal in one (Fig. II). A  
disturbance or absence of sarcomeric proteins like 
myosin (Fig. ID) and titin (Figs. 1J,K) was observed in
the cores of some patients but not in the apparently 
non-affected parts of the muscle fibres,
Nemaline myopathy (NM; Fig. 2)
Muscle fibre areas in biopsies of five NM patients 
containing nemaline rods were identified by the modi­
fied Gomori trichrome stain (Figs. 2A,B). In biopsies 
of the severe cases (NM1, NM3, NM5) almost all fibres 
contained rods (Fig. 2A) while in the other biopsies
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predominantly small, slow fibres were affected (Fig. 
2B). An increased, diffuse desmin reactivity was ob­
served in most fibres of patients with the severe neona­
tal form (Fig. 2F). In the moderately affected patients 
NM2 and NM4 only small fibres showed a disturbance 
in desmin distribution (Fig. 2E). This disturbance was 
not restricted to subsarcolemmal parts of the muscle 
fibres where rods usually are localized. The biopsy 
material of patient NM5 showed besides rods also 
core-like structures. Despite the abnormal desmin dis­
tribution (Fig. 2C), most fibres still showed a cross-stri­
ated staining pattern with anti-desmin (Fig, 2D). A  
diffuse vimentin staining reaction and the presence of 
embryonic myosin in several muscle fibres was only 
seen in the youngest NM patient (Figs. 2G,H). In 
severe neonatal cases small fibres were often of the 
fast-twitch type, while in the other cases the small, 
rod-containing fibres were predominantly of the slow- 
twitch type. Expression of basement membrane pro­
teins was increased around fibres and blood vessels in 
severe neonatal cases (Fig. 21). This phenomenon was 
accompanied by a punctate collagen type IV deposition 
in the perimysium (Fig. 21). Anti-collagen type VI 
staining showed a slight to strong increase in en- 
domysial and perimysial tissues in severe cases (Fig, 
2J), but a normal connective tissue compartment in 
other cases (Fig. 2K). Reaction patterns with antibod­
ies to sarcomeric proteins such as titin (Fig. 2L) varied 
considerably according to the accuracy of cross-section­
ing of the fibres. The patterns were not considered to 
be abnormal.
X-linked myotubular myopathy (XLMTM; Figs. 3 -5 )  
Biopsy specimens of our four XLMTM patients 
were characterized by a strong desmin staining of the 
central area of a large majority of the muscle fibres in 
all patients (Figs. 3A -C , 5A). Despite this abnormal 
desmin distribution, longitudinally sectioned muscle fi­
bres showed a relatively normal cross-striated pattern 
when stained with anti-desmin (Fig. 31) and anti-titin 
(Fig, 3J). The vimentin staining pattern (Figs. 4A -D , 
5B) was comparable (though often weaker) to that of 
desmin (Figs. 3A -C , 5A) and included cross-striations 
(Fig. 4B). However, many large fibres did not contain 
vimentin (Figs. 4A, 5B), while the number of vimentin 
containing fibres showed considerable variation among 
patients and seemed to decrease with the age (Figs. 
4A -D ). Upon staining with the anti-embryonic myosin 
antibodies a similar, age-dependent decrease in expres­
sion was observed (Figs. 4E -G ). In serial sections of 
the muscle biopsy of patient XLMTM1 all fibres that 
expressed embiyonic myosin were also stained by the 
anti-desmin and anti-vimentin antibodies (Figs. 5A-C). 
Some embryonic myosin negative fibres expressed 
desmin and vimentin, while most large fibres negative 
for embryonic myosin, expressed desmin but not vi­
mentin (Figs. 5A -C ). The large fibres in this biopsy 
that were negative for embryonic myosin were, how-
Table 4
Distribution patterns of the basement membrane components laminin and collagen IV and the reticular layer constituent collagen VI
Patient Laminin/collagen type IV Collagen type VI
CCD I normal endomysial staining slightly increased
CCD 2 increased expression around muscle fibres and blood increased staining of endomysial and perimysial connective
vessels; expression of collagen type IV in perimysium tissue
CCD 3 normal normal
CCD4 slightly increased reactivity slightly increased reactivity
CCD 5 normal normal to slightly increased reactivity
NM1 increased expression around muscle fibres and blood all fibres embedded in increased amounts of strongly
vessels; expression of collagen type IV in perimysium stained connective tissue
NM2 normal normal
NM3 increased expression around muscle fibres and blood 




XLMTM 1 nd nd
XLMTM2 slightly increased staining around muscle fibres and blood slightly increased staining of endomysium; perimysium
vessels normal
XLMTM3 slightly increased expression; expression of collagen type slightly increased staining of endomysial and perimysial
IV in perimysium tissue
XLMTM4 nd nd
CNM1 normal normal
CNM2 increased expression around all muscle fibres and blood 
vessels
increased staining of endomysium; perimysium normal
nd: not done.
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ever, found to express the slow myosin heavy chain 
(Figs. 5D,E). Several other, smaller fibres co-expressed 
embryonic myosin and an adult form of myosin (Figs.
5D,E).
The two XLMTM patients that were studied with 
antibodies to laminin, collagen type IV and collagen 
type VI, showed an increased basement membrane 
labelling with anti-laminin and anti-collagen type IV 
around muscle fibres and blood vessels (Figs. 3D-F). 
Expression of collagen type IV in perimysial tissue was
observed in one of these patients (Fig. 3F). Collagen 
type VI reactivity was increased in the endomysial 
tissue of both patients (Fig. 3G). Only one of the 
patients showed increased collagen type VI expression 
in the perimysial connective tissue. Like in all other 
cases of normal and pathological skeletal muscle, anti- 
nebulin diffusely stained the fibres in XLMTM. In 
most XLMTM fibres the reactivity in their central 
region was absent or less intense when compared to 
other parts of the fibres (Fig. 3H). Ultrastructurally, we
Fig. 3. X-linked myotubular myopathy. Immunofluorescence micrographs of muscle tissue of patients XLMTM1  (A), XLMTM 2 (B,D,E,G,I,J), 
XLMTM3 (F) and XLMTM4 (C,H) incubated with the monoclonal anti-desmin RD 301 (A,C) or polyclonal anti-desmin (B,I), anti-laminin (D), 
anti-collagen type IV (E,F), anti-collagen type VI (G), anti-nebulin (H) or anti-titin (J). Bar = 50 /¿m (A-E, G-J) or 100 (im  (F).
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Fig. 4. X-linked myotubular myopathy. Immunofluorescence micrographs of muscle tissue of patients XLMTM1 (A,B,E), XLMTM 2 (C), 
XLMTM3 (F) and XLMTM4 (D,G) incubated with the monoclonal vimentin antibody RV202 (A,B,D) 0r polyclonal vimentin antiserum (C), or 
the monoclonal antibodies to embryonic myosin 330-R5D4 (E) or 330-R5B4 (F,G), Note the age-dependent decrease in the number of vimentin 
positive fibres from A through D, and the decrease in the number of embryonic myosin positive fibres from E through G, The section shown in D 
contains a single vimentin-positive fibre (arrow). Bar = 50 jLtm.
observed accumulations of intermediate filaments in 
the perinuclear areas that showed increased intermy- 
ofibrillar space (not shown).
Centronuclear myopathy (CNM; Fig. 6)
Most of the results concerning patient CNM2 were 
described and illustrated before (Van der Ven et aL,
1991). Upon NADH-TR staining the fibres in the CNM 
biopsies often showed a strong central reactivity and a 
peripheral halo (Fig. 6A) or a radial spoke-like appear­
ance. Increased anti-desmin staining was observed in 
muscle biopsies of both patients studied. In patient 
CNM1 specifically small, slow twitch fibres (Fig. 6E) 
showed a disturbed desmin distribution pattern (Fig. 
6B), while in patient CNM2 both fibre types were 
affected. In longitudinal sections a normal cross-stria- 
ted desmin reactivity was observed surrounding the 
strongly stained centre of the fibres (Fig. 6C). As 
described before, patient CNM2 showed cytoplasmic 
aggregates of vimentin. No vimentin reactivity was ob­
served in the muscle fibres of the other patient (Fig. 
6D). Embryonic myosin was only detected in a few
scattered fibres in one of the patients. Expression of 
basement membrane and reticular layer proteins was 
normal in patient CNM1 (Figs. 6F,G). Patient CNM2, 
however, showed an overtly increased expression of 
laminin and collagen type IV around muscle fibres and 
blood vessels and an increased endomysial collagen 
type VI expression (Fig. 6H). Expression and distribu­
tion of titin was only studied in patient CNM1. Com­
pared to small fibres, large fibres seemed to be stained 
a little stronger and more regular (Fig, 61),
4. Discussion
The normal function of skeletal muscle depends 
primarily on a correct assembly of myofibrils, in partic­
ular the organization of the sarcomeric units. Next to 
the motor proteins actin and myosin, several other 
muscle cell constituents play an important role in this 
process. The high molecular weight proteins titin and 
nebulin assumedly help organize the myosin and actin 
filaments into a regular geometric pattern (Fulton and
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Isaacs, 1991; Trinick, 1992). The muscle specific inter­
mediate filament protein desmin (Fischman, 1986) and 
probably also skelemin (Price, 1987) link adjacent my­
ofibrils to each other at the level of the Z-line and the 
M-line, respectively, in order to keep myofibrils in 
register during contraction. The same filament proteins 
anchor myofibrils to a subsarcolemmal network con­
taining dystrophin that co-localizes with a-actinin, vin- 
culin and other proteins known to occur in adhesion 
plaques (Ahn and Kunkel, 1993). Dystrophin associates 
with a laminin-binding transmembrane complex of 
glycoproteins, while integrins are thought to provide a 
further link to the interstitial connective tissue, the 
reticular layer (Ahn and Kunkel, 1993; Ervasti and 
Campbell, 1993), that contains the microfibril-forming 
collagen type VI (Hessle and Engvall, 1984), The force 
generated by myofibril contraction is not only transmit­
ted to the tendon via the myotendinous junction, but 
also through the endomysial and perimysial tissue. It is 
evident that any disturbance of the described protein- 
protein interactions might cause muscle weakness. It is 
therefore that we have undertaken this study on the 
expression and localization of sarcomeric, cytoskeletal
and extracellular matrix components of diseased mus­
cle.
Desmin disorganization as a marker for congenital my­
opathy
One of the most striking observations from our 
study is the wide-spread disturbance of desmin local­
ization in CM. Altered expression patterns of the inter­
mediate filament proteins (IFPs) desmin and vimentin 
have been described to be associated with regeneration 
by several authors (Thornell et al., 1980,1983; Helliwell 
et al., 1989; Gallanti et al., 1992; Bornemann and 
Schmalbruch, 1992), The presence of regenerating fi­
bres in a muscle biopsy is associated with several 
myopathies (e.g. Duchenne muscular dystrophy, myosi­
tis, CM). Therefore, the increased IFP-expression ob­
served in these fibres, can not be considered specific 
for CM. In all studied cases of CCD, NM, XLMTM 
and CNM an abnormal desmin distribution was ob­
served, which could not be correlated to the presence 
of regenerating fibres. The different desmin staining 
patterns in CCD were described before (Thornell et 
al., 1983; Gallanti et al., 1992) and are probably related
Fig. 5. X-linked myotubular myopathy. Immunofluorescence micrographs of serial sections (A-C, D -E ) of muscle tissue of patient XLMTM 1 
stained with monoclonal anti-desmin (RD301, A), monoclonal anti-vimentin (B), anti-embryonic myosin (330-R5D4, C,D) or anti-slow myosin 
heavy chain (E). Corresponding fibres are indicated by arrows. Bar = 50 fim .
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to the presence of structured and unstructured cores 
(Bodensteiner, 1994). In NM, abnormal desmin stain­
ing patterns were exclusively found in all rod-contain­
ing fibres. Our results provided however, further evi­
dence against desmin as a component of nemaline 
rods. Our results in XLMTM differ from those of 
Sarnat (1990), in that desmin staining in the centre of 
the fibres was much stronger when compared to the 
periphery, while Sarnat reported an overall staining of
muscle fibres. The desmin staining patterns obtained in 
this study correspond, however, well to the ultrastruc- 
turally observed accumulations of intermediate fila­
ments. The differences in staining patterns might result 
from the sensitivity of the immunofluorescence tech­
nique, or the specificity of the desmin antibodies. In 
our hands, anti-desmin monoclonal antibody D3 stained 
XLMTM myofibres less abundantly than RD301 and 
pDes. Differential staining patterns of serial skeletal
Fig. 6. Centronuclear myopathy. NADH-TR (A) or immunofluorescent (B-I) staining of muscle tissue of patients CNM1 (A -G , I) or CNM2 
(H). Sections are incubated with polyclonal anti-desmin (BjC), polyclonal anti-vimentin (D), anti-fast myosin light chain (E), anti-laminin (F), 
anti-collagen type VI (G,H) or anti-titin (I). Corresponding fibres in A  and B are indicated by arrows. Note the disturbed desmin pattern (arrow 
in C) in the centre of a longitudinally sectioned fibre. Bar = 50 /¿m (A,B>C,G,H) or 100 jam (D 3E 3F,I)-
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muscle sections with different antibodies to desmin 
were also noted by Helliwell et al. (1989). Increased 
desmin staining in the centre of the fibre was observed 
in a number of CNM cases (Van der Ven et al, 1991, 
Misra et al.5 1992). This reactivity pattern is not found 
in muscle biopsies of patients with e.g. myotonic dys­
trophy that are also characterized by numerous inter­
nal nuclei (Van der Ven et a l, unpublished results; 
Sarnat, 1992) and can thus be considered as specific for 
CNM.
The abnormal desmin localization in CNM might be 
a result of developmental regression (Misra et al.,
1992). The observation that nuclei centralize postna- 
tally in some patients (Van der Ven et al., 1991) 
supports this idea. Desmin is found in a cross-striated 
pattern only in a progressed stage of myofibrillogenesis 
(Van der Ven et al., 1992, Van der Ven et a l, 1993). It 
is therefore conceivable that desmin is one of the first 
proteins to be redistributed during dedifferentiation of 
muscle cells.
Age-related changes in expression of differentiation 
markers in X LM TM
In XLMTM patients skeletal muscle fibres show 
features of immaturity and it was therefore suggested 
that the disease is associated with a partial arrest of 
morphogenesis (Sarnat, 1990). On the one hand, the 
presence of vimentin and embryonic myosin, and the 
distribution pattern of desmin as described in the un­
derlying study, point to a deranged process of matura­
tion. On the other hand, our results confirm the obser­
vation that XLMTM myofibres are mature in other 
aspects of development, e.g. differentiation of fibre 
types (Sarnat, 1990; Sawchak et al., 1991; Soussi-Yani- 
costas et al., 1991). The normal alignment of adjacent 
myofibrils (Sarnat, 1990), results in a cross-striated 
pattern upon staining with anti-desmin and anti-titin 
antibodies and provides further proof for a normal 
progression of certain maturation processes in this 
disease. Due to the lack of serial biopsies of XLMTM 
patients, progression of the disease and possible post­
natal fibre-maturation have scarcely ever been studied. 
In two brothers, one born at 28 weeks of gestation and 
the other at term, markedly increased pathologic find­
ings were found in the latter (Braga et al., 1990), 
suggesting prenatal progression. In one case of 
XLMTM described by Sarnat et al. (1981), no postna­
tal morphologic maturation was observed between the 
age of 5 days and 9 months. Examination of muscle 
biopsies from two other brothers suffering from 
XLMTM, revealed that the fibre diameter increases 
with developmental age (Sawchak et al., 1991), impli­
cating that XLMTM muscle fibres mature postnatally. 
Our studies concerning 4 XLMTM patients that vary in 
age from 1 week to 4 months, and whose biopsies show 
an age-dependent down-regulation of vimentin and
embryonic myosin, support the suggestion that 
XLMTM muscle matures postnatally. However, it can­
not be excluded that the time point of maturational 
arrest varies in individual patients.
Relation o f  clinical data with immunohistologic results: 
(A) central core disease
Variations in clinical expression have been de­
scribed for several muscle diseases. Some of these 
variations are the result of mutations in different genes. 
For example, mutations in the ryanodine receptor gene 
(Zhang et al., 1993) and the /3-myosin heavy chain gene 
(Fananapazir et al., 1993), both resulting in a CCD 
phenotype may explain the considerable variation of 
clinical features in CCD patients. The clinical differ­
ences in CCD patients within one family illustrate that 
the same mutation can also result in different clinical 
phenotypes. Included in our study are a father and his 
daughter both with CCD, Although in both cases the 
same genetic mutation most probably underlies the 
CCD phenotype, clinical expressions varied consider­
ably. Immunohistochemical experiments revealed that 
in the muscle biopsy of the severely affected daughter 
expression of basement membrane and reticular layer 
proteins were increased. Moreover, the daughter’s 
muscle biopsy contained only slow-twitch fibres that 
were all affected, while the muscle biopsy of the father 
only showed a predominance of affected slow-twitch 
fibres. The presence of 20% non-affected fast-twitch 
fibres might explain the relatively mild symptoms in the 
father. In the biopsies of other investigated CCD pa­
tients, that were all clinically affected in early child­
hood, very few, if any, fast-twitch fibres were present. 
Moreover, the muscle biopsy of the most severely af­
fected patient (CCD2), showed apart from necrotic 
fibres and replacement of muscle fibres by adipose 
tissue, also increased expression of basement mem­
brane and reticular layer proteins.
Relation o f  clinical data with immunohistologic results:
B. Nemaline myopathy
When immunocytochemical data are compared with 
the phenotype in NM, three subgroups should be dis­
cerned: (i) the neonatal; (ii) the moderate congenital; 
and (iii) the adult onset form (Shimomura and Nonaka, 
1989; Bodensteiner, 1994). Obvious signs of immaturity 
were observed in the biopsies of patients with the 
severe neonatal form, like the presence of several 
embryonic myosin and vimentin-positive fibres and the 
diffuse desmin distribution in all fibres. The desmin 
and vimentin staining patterns clearly differed from 
those in XLMTM. Furthermore, the severe neonatal 
NM cases showed an increase of laminin, collagen type 
IV and especially collagen type VI expression, associ­
ated with an unusual presence of collagen type IV in 
the perimysium. This was particularly obvious in case
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NM3. These patterns were not observed in an age- 
matched, much less affected patient with the moderate 
congenital form of NM. Muscle weakness in NM pa­
tients was reported not to be associated to the number 
of rods, but to the degree of predominance and/or  
atrophy of slow-twitch fibres (Bodensteiner, 1994). In 
our cases the severely affected adult-onset NM patient 
shows a high predominance of slow-twitch fibres, while 
in the adult patient with mild symptoms distinctly less 
slow-twitch fibres were observed. This observation sup­
ports the suggestion of Shimomura and Nonaka (1989) 
that progression in NM is associated with an ongoing 
change of fibre types from fast-twitch to slow-twitch. In 
this respect, it is interesting to note that both, Volpe et 
al. (1982) and Miike et al. (1986) provided indications 
for a change of myosin expression from fast to slow in 
NM.
Linkage studies have recently assigned the autoso­
mal dominant form of NM, to chromosome 1 between 
lp l3  and lq25.1 (Laing et al., 1992), while linkage of 
the autosomal recessive form to this region was ex­
cluded (Tahvanainen et al., 1994). This indicates that 
these forms of NM are caused by different genetic 
mutations, and might explain the different observed 
staining patterns.
Relation o f  clinical data with immunohistologic results:
C. Myotubular /  centronuclear myopathy
When compared to other types of CM, XLMTM 
patients are a relatively homogeneous group with a 
high mortality rate (Bodensteiner, 1994). Our immuno- 
histochemical findings are relatively uniform and, apart 
from the differences already discussed, in accordance 
with the literature as far as IFPs and myosin isoforms 
are concerned (Sarnat, 1990; Sawchak et a l, 1991; 
Soussi-Yanicostas et al., 1991). Notable is the in­
creased expression of collagens type IV and VI as well 
as laminin in this severe type of myopathy. A correla­
tion between an increased expression of extracellular 
matrix proteins and the severity of CM, is also sup­
ported by our finding that in one of the CNM cases, in 
contrast with a second, less-affected case, high amounts 
of these constituents were found. Furthermore, the 
muscle biopsy of the former patient showed abnormali­
ties in both fibre types as well as the presence of 
vimentin aggregates in numerous fibres, while in the 
biopsy of the latter, all fast-twitch fibres were unaf­
fected, and no vimentin was detected in any of the 
fibres.
S. Conclusions
The molecular phenotype of pathologic skeletal 
muscle fibres in CM can be severely disturbed when 
compared to normal myofibres. Intra- and extracellular
changes in the expression and organization of struc­
tural proteins can however vary considerably between 
different types of CM, but also within one type of CM. 
Correlations between these changes at the molecular 
level on the one hand, and the clinical phenotype on 
the other hand were observed. In case of fibre type- 
specific defects, the percentage of non-affected fibres 
could be correlated with clinical presentation. These 
fibres may compensate for the weakness caused by the 
affected fibres. Severe clinical phenotypes are accom­
panied by an increased deposition of basement mem­
brane and reticular layer proteins, implicating that 
these compartments may play a role in the develop­
ment of muscular weakness. We can, however, not 
exclude that this increase represents the result of the 
course of the disease. The age-related differences in 
expression of embryonic myosin and vimentin in biop­
sies of XLMTM patients are either the result of post­
natal maturation, or a variable time-point of matura- 
tional arrest in individual patients. The disturbed 
desmin staining patterns seen in our patients are unique 
for each type of CM and appear useful for diagnostic 
purposes.
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